Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 12 filings · Latest: May 11, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Rodman David MalcomMar 17, 2026
Proposed Sale
$25.65417$10.7K
MLYS
David Malcom RodmanChief Medical OfficerMar 17, 2026
Sale
$25.65417$10.7K76,140
MLYS
David Malcom RodmanChief Medical OfficerMar 17, 2026
Option Exercise
$15.44417$6.4K76,557
MLYS
David Malcom RodmanChief Medical OfficerMar 13, 2026
Sale
$26.2614,058$369.2K76,140
MLYS
David Malcom RodmanChief Medical OfficerMar 13, 2026
Option Exercise
$12.397,709$95.5K90,198
MLYS
David Malcom RodmanChief Medical OfficerMar 12, 2026
Sale
$27.376,348$173.7K82,489
MLYS
David Malcom RodmanChief Medical OfficerMar 12, 2026
Option Exercise
$1.086,348$6.9K88,837
MLYS
Rodman David MalcomMar 13, 2026
Proposed Sale
$26.2614,058$369.2K
MLYS
Rodman David MalcomMar 12, 2026
Proposed Sale
$27.376,348$173.7K
MLYS
David Malcom RodmanChief Medical OfficerMar 9, 2026
Sale
$26.842,171$58.3K82,489
MLYS
David Malcom RodmanChief Medical OfficerMar 9, 2026
Option Exercise
$16.002,171$34.7K84,660
MLYS
Rodman David MalcomMar 9, 2026
Proposed Sale
$26.842,171$58.3K
MLYS
David Malcom RodmanChief Medical OfficerFeb 17, 2026
Sale
$27.59417$11.5K44,089
MLYS
David Malcom RodmanChief Medical OfficerFeb 17, 2026
Option Exercise
$15.44417$6.4K44,506
MLYS
Rodman David MalcomFeb 17, 2026
Proposed Sale
$27.59417$11.5K
MLYS
David Malcom RodmanChief Medical OfficerFeb 13, 2026
Sale
$27.4414,055$385.7K44,089
MLYS
David Malcom RodmanChief Medical OfficerFeb 13, 2026
Option Exercise
$12.397,707$95.5K54,603
MLYS
David Malcom RodmanChief Medical OfficerFeb 12, 2026
Sale
$28.996,349$184.1K50,437
MLYS
David Malcom RodmanChief Medical OfficerFeb 12, 2026
Option Exercise
$1.086,349$6.9K56,786
MLYS
Rodman David MalcomFeb 13, 2026
Proposed Sale
$27.4414,055$385.7K